 | Up a level |
Perotti, Daniela; Williams, Richard D; Wegert, Jenny; Brzezinski, Jack; Maschietto, Mariana; Ciceri, Sara; Gisselsson, David; Gadd, Samantha; Walz, Amy L; Furtwängler, Rhoikos; Drost, Jarno; Al-Saadi, Reem; Evageliou, Nicholas; Gooskens, Saskia L; Hong, Andrew L; Murphy, Andrew J; Ortiz, Michael V; O'Sullivan, Maureen J; Mullen, Elizabeth A; van den Heuvel-Eibrink, Marry M; ... (2024). Hallmark discoveries in the biology of Wilms tumour. Nature Reviews. Urology, 21(3), pp. 158-180. Nature Publishing Group 10.1038/s41585-023-00824-0
Wegert, Jenny; Fischer, Anne Kristin; Palhazi, Balazs; Treger, Taryn D; Hilgers, Cäcilia; Ziegler, Barbara; Jung, Hyunchul; Jüttner, Eva; Waha, Andreas; Fuchs, Jörg; Warmann, Steven W; Frühwald, Michael C; Hubertus, Jochen; Pritchard-Jones, Kathy; Graf, Norbert; Behjati, Sam; Furtwängler, Rhoikos; Gessler, Manfred; Vokuhl, Christian (2024). TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants. The journal of pathology, 262(1), pp. 10-21. Wiley 10.1002/path.6206
Kneitz, Burkhard; Krebs, Markus; Kalogirou, Charis; Schubert, Maria; Joniau, Steven; van Poppel, Hein; Lerut, Evelyne; Kneitz, Susanne; Scholz, Claus Jürgen; Ströbel, Philipp; Gessler, Manfred; Riedmiller, Hubertus; Spahn, Martin (2014). Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3. Cancer research, 74(9), pp. 2591-2603. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-13-1606
